Diagnosis, treatment, and work impact of iron deficiency anemia in a Portuguese urban community

Introduction: Little is known about iron deficiency anemia (IDA)'s treatment in Portugal. We aim to estimate the proportion of anemia, IDA, and iron deficiency without anemia; characterize the diagnostic procedures and prescription patterns; assess anemia's impact over work absenteeism, in...

Full description

Bibliographic Details
Main Author: Norton, P (author)
Other Authors: Araújo, N (author), Pinho, P (author), Costa Gomes, J (author), Silva, C (author), Gama, C (author), Barbosa, M (author), Ferreira, P (author), Cunha, S (author), Moreira, S (author), Martins, S (author), Faria, S (author), Sousa, S (author), Figueiras, Alves, N (author), Lunet, N (author)
Format: article
Language:eng
Published: 2020
Subjects:
Online Access:https://hdl.handle.net/10216/143377
Country:Portugal
Oai:oai:repositorio-aberto.up.pt:10216/143377
Description
Summary:Introduction: Little is known about iron deficiency anemia (IDA)'s treatment in Portugal. We aim to estimate the proportion of anemia, IDA, and iron deficiency without anemia; characterize the diagnostic procedures and prescription patterns; assess anemia's impact over work absenteeism, in a Local Health Unit. Material and methods: Cross-sectional study that evaluated complete blood counts, iron-containing prescriptions, comorbidities, economic failure, and disability certificates issued in 2015 at the Local Health Unit. Results: We evaluated 62,794 complete blood count. The proportion of anemia was 16.5%, higher in patients with economic failure, pregnant women, and patients with congestive heart failure. Of the patients with anemia 87.8% had not serum iron and/or ferritin dosing, and of those with serum iron/ferritin levels tested 50.6% had IDA. IDA was higher in pregnant women, women aged ≥15 years and in patients with congestive heart failure. Approximately 56.2% of patients with IDA did not receive iron-containing medication, and in 38% of the cases the prescribed dose was subtherapeutic. Of the total iron prescriptions 44.1% were association therapies. Anemia accounted for 5.2% of the disability certificates issued in 2015 (1749 workdays lost). Discussion: Most patients with anemia are not being adequately evaluated and a major proportion does not undergo treatment or has subtherapeutic doses of iron. These results may explain the anemia's impact on work capacity. Conclusion: This is one of the largest studies on anemia in Portugal. An effort to adapt to the established recommendations is urged, to minimize the consequences of this disease.